[go: up one dir, main page]

BR9605969A - Método para a reduçao de extensao de infrato em individuos afligidos com doença de coraçao isquemica - Google Patents

Método para a reduçao de extensao de infrato em individuos afligidos com doença de coraçao isquemica

Info

Publication number
BR9605969A
BR9605969A BR9605969A BR9605969A BR9605969A BR 9605969 A BR9605969 A BR 9605969A BR 9605969 A BR9605969 A BR 9605969A BR 9605969 A BR9605969 A BR 9605969A BR 9605969 A BR9605969 A BR 9605969A
Authority
BR
Brazil
Prior art keywords
infringement
extent
reducing
heart disease
ischemic heart
Prior art date
Application number
BR9605969A
Other languages
English (en)
Inventor
Masafumi Kitakaze
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR9605969A publication Critical patent/BR9605969A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
BR9605969A 1995-12-12 1996-12-11 Método para a reduçao de extensao de infrato em individuos afligidos com doença de coraçao isquemica BR9605969A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/570,767 US5700803A (en) 1995-12-12 1995-12-12 Method for reducing infarct size in subjects afflicted with ischemic heart disease

Publications (1)

Publication Number Publication Date
BR9605969A true BR9605969A (pt) 1998-08-18

Family

ID=24280985

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9605969A BR9605969A (pt) 1995-12-12 1996-12-11 Método para a reduçao de extensao de infrato em individuos afligidos com doença de coraçao isquemica

Country Status (9)

Country Link
US (1) US5700803A (pt)
EP (1) EP0782856A1 (pt)
JP (1) JP4045376B2 (pt)
KR (1) KR970032865A (pt)
CN (1) CN1157718A (pt)
AR (1) AR004371A1 (pt)
AU (1) AU7413796A (pt)
BR (1) BR9605969A (pt)
CA (1) CA2192518A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4120713B2 (ja) * 1997-09-04 2008-07-16 大塚製薬株式会社 多発性硬化症治療剤
US5998386A (en) * 1997-09-19 1999-12-07 Feldman; Arthur M. Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue
KR100446432B1 (ko) * 2001-08-13 2004-08-30 한국화학연구원 2-벤조티아졸 카바페넴 유도체 및 그의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0552373B1 (en) * 1991-07-03 1999-10-13 Otsuka Pharmaceutical Co., Ltd. Apoptosis regulator
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication

Also Published As

Publication number Publication date
CA2192518A1 (en) 1997-06-13
AU7413796A (en) 1997-06-19
CN1157718A (zh) 1997-08-27
MX9606345A (es) 1997-10-31
JPH09165338A (ja) 1997-06-24
US5700803A (en) 1997-12-23
JP4045376B2 (ja) 2008-02-13
KR970032865A (ko) 1997-07-22
EP0782856A1 (en) 1997-07-09
AR004371A1 (es) 1998-11-04

Similar Documents

Publication Publication Date Title
DE69621311D1 (de) Cachespeicherkohärenzverfahren und-system
DE69604860D1 (de) Orthopädisches Befestigungsmittel
NO970315D0 (no) Datamaskinsystem med klient/tjener-arkitektur
DE69627348D1 (de) Mikroprismatische matrix
BR9605702A (pt) Alourante para cabelos humanos
PT909270E (pt) Processo para a preparacao de 2,4-dihidroxipiridina e de 2,4-dihidroxi-3-nitropiridina
FI955216L (fi) Menetelmä rullauksessa
BR9507494A (pt) Processo para a preparação de famciclovi de 2-amino-6-cloro purina e processo para a preparação de penciclovi de 2-amino-6- cloro purina
BR9611787A (pt) Folha adesiva processo para produção de uma folha adesiva e estrutura tendo uma folha adesiva aderida
FI972186L (fi) Menetelmä isomaltuloosin ja muiden tuotteiden valmistamiseksi
DE69605696D1 (de) Festlegungs- und Umfüllungssystem
BR9605969A (pt) Método para a reduçao de extensao de infrato em individuos afligidos com doença de coraçao isquemica
DE19882530T1 (de) Kaltformungsverfahren und -vorrichtung
DE69614890D1 (de) Hautstreckmaschine
FI955496A7 (fi) Synkroninen datansiirtomenetelmä ja -järjestely
ATE397073T1 (de) Menschliche dnase i varianten
FI971257A0 (fi) Kylmämuovausmenetelmä
FI973755A0 (fi) Viistokantaniitti
FI955112A0 (fi) Menetelmä ja sovitelma lämmön siirtämiseksi
DE59608075D1 (de) Intrakorporales behandlungssystem
ES1032528Y (es) Traje perfeccionado para masaje y baño.
KR970006219A (ko) 셀화된 무기질 바디 및 이의 제조방법
BR7500576U (pt) Disposição aplicada em preservativo para seios
ES1024288Y (es) Pinza para la sujecion de toallas y similares.
BR7501042U (pt) Disposiç o aplicada em suporte para bobinas e similares

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law